Interaction of caveolin‐1, nitric oxide, and nitric oxide synthases in hypoxic human SK‐N‐MC neuroblastoma cells

Abstract Neuroblastoma cells are capable of hypoxic adaptation, but the mechanisms involved are not fully understood. We hypothesized that caveolin‐1 (cav‐1), a plasma membrane signal molecule, might play a role in protecting neuroblastoma cells from oxidative injury by modulating nitric oxide (NO) production. We investigated the alterations of cav‐1, cav‐2, nitric oxide synthases (NOS), and NO levels in human SK‐N‐MC neuroblastoma cells exposed to hypoxia with 2% [O 2 ]. The major discoveries include: (i) cav‐1 but not cav‐2 was up‐regulated in the cells exposed to 15 h of hypoxia; (ii) NO donor 1‐[ N , N ‐di‐(2‐aminoethyl) amino] diazen‐1‐ium‐1, 2‐diolate up‐regulated the expression of cav‐1, whereas the non‐selective NOS inhibitor N G ‐nitro‐ l ‐arginine methyl ester and inducible NOS (iNOS) inhibitor 1400W each abolished the increase in cav‐1 expression in the hypoxic SK‐N‐MC cells. These results suggest that iNOS‐induced NO production contributes to the up‐regulation of cav‐1 in the hypoxic SK‐N‐MC cells. Furthermore, we studied the roles played by cav‐1 in regulating NO, NOS, and apoptotic cell death in the SK‐N‐MC cells subjected to 15 h of hypoxic treatment. Both cav‐1 transfection and cav‐1 scaffolding domain peptide abolished the induction of iNOS, reduced the production of NO, and reduced the rates of apoptotic cell death in the hypoxic SK‐N‐MC cells. These results suggest that increased expression of cav‐1 in response to hypoxic stimulation could prevent oxidative injury induced by reactive oxygen species. The interactions of cav‐1, NO, and NOS could be an important signal pathway in protecting the neuroblastoma cells from oxidative injury, contributing to the hypoxic tolerance of neuroblastoma cells.